To apply for the PGY2 Drug Information Residency Program, you must:
Selection of the resident is based on evaluation of college transcripts, letters of recommendation and a full day, on-site interview. Applicants will be contacted by mid February to either schedule an on-site interview or to be informed that their application has been declined.
To help preserve and improve the health of its patients, their families and its employees, The Children’s Hospital of Philadelphia implemented a tobacco-free hiring policy. This policy applies to all candidates for employment (other than those with regularly scheduled hours in New Jersey) for all positions, including those covered by the Collective Bargaining Agreement.
Job applicants who apply after July 1, 2013 will be expected to sign an attestation stating they’ve been free of nicotine or tobacco products in any form for the prior thirty (30) days. They will also undergo a cotinine test as a part of the Occupational health pre-placement drug screen administered after the offer of employment has been accepted but before the first day of hire.
Exemptions: Attending Physicians (excluding CHOP Physicians in the Care Network), Psychologists, Principal Investigators and/or Penn-Based Faculty are exempt from this process to better align with our colleagues at the University of Pennsylvania Perelman School of Medicine.
The Children's Hospital of Philadelphia's Residency in Drug Information program requires the following materials for the application process:
Please submit the application electronically by January 10, 2014 to Connie Law, email@example.com.
Mailing address for transcripts (if applicable):
The Children’s Hospital of Philadelphia
Department of Pharmacy Services
34th Street and Civic Center Blvd
Philadelphia, PA 19104
If you have any questions about the Pharmacy Residency Program, please use our online form to contact us.